156 related articles for article (PubMed ID: 33288196)
1. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.
Hasehira K; Furuta T; Shimomura O; Asada M; Oda T; Tateno H
Biochem Biophys Res Commun; 2021 Jan; 534():310-316. PubMed ID: 33288196
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells.
Furuta T; Oda T; Kiyoi K; Yusuke O; Kimura S; Kurimori K; Miyazaki Y; Yu Y; Furuya K; Akashi Y; Shimomura O; Tateno H
Cancer Sci; 2021 Sep; 112(9):3722-3731. PubMed ID: 34115906
[TBL] [Abstract][Full Text] [Related]
3. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
[TBL] [Abstract][Full Text] [Related]
4. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.
Sagar S; Leiphrakpam PD; Thomas D; McAndrews KL; Caffrey TC; Swanson BJ; Clausen H; Wandall HH; Hollingsworth MA; Radhakrishnan P
Cancer Lett; 2021 Apr; 503():91-102. PubMed ID: 33485947
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
[TBL] [Abstract][Full Text] [Related]
6. Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer:
Kuroda Y; Oda T; Shimomura O; Louphrasitthiphol P; Mathis BJ; Tateno H; Hatano K
Cancer Sci; 2023 Aug; 114(8):3364-3373. PubMed ID: 37203465
[TBL] [Abstract][Full Text] [Related]
7. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
8. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.
Bassagañas S; Allende H; Cobler L; Ortiz MR; Llop E; de Bolós C; Peracaula R
Cytokine; 2015 Sep; 75(1):197-206. PubMed ID: 25934648
[TBL] [Abstract][Full Text] [Related]
10. Fucosyltransferase 8 plays a crucial role in the invasion and metastasis of pancreatic ductal adenocarcinoma.
Tada K; Ohta M; Hidano S; Watanabe K; Hirashita T; Oshima Y; Fujnaga A; Nakanuma H; Masuda T; Endo Y; Takeuchi Y; Iwashita Y; Kobayashi T; Inomata M
Surg Today; 2020 Jul; 50(7):767-777. PubMed ID: 31950256
[TBL] [Abstract][Full Text] [Related]
11. Novel Pancreatic Cancer Therapy Targeting Cell Surface Glycans by Liposomes Modified with rBC2LCN Lectin.
Kimura S; Oda T; Shimomura O; Enomoto T; Hashimoto S; Kuroda Y; Yu Y; Kurimori K; Furuta T; Miyazaki Y; Tateno H
Eur Surg Res; 2020; 61(4-5):113-122. PubMed ID: 33503609
[TBL] [Abstract][Full Text] [Related]
12. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
13. Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
Radhakrishnan P; Dabelsteen S; Madsen FB; Francavilla C; Kopp KL; Steentoft C; Vakhrushev SY; Olsen JV; Hansen L; Bennett EP; Woetmann A; Yin G; Chen L; Song H; Bak M; Hlady RA; Peters SL; Opavsky R; Thode C; Qvortrup K; Schjoldager KT; Clausen H; Hollingsworth MA; Wandall HH
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):E4066-75. PubMed ID: 25118277
[TBL] [Abstract][Full Text] [Related]
14. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
[TBL] [Abstract][Full Text] [Related]
15. rBC2LCN-reactive SERPINA3 is a glycobiomarker candidate for pancreatic ductal adenocarcinoma.
Mawaribuchi S; Shimomura O; Oda T; Hiemori K; Shimizu K; Yamase K; Date M; Tateno H
Glycobiology; 2023 May; 33(4):342-352. PubMed ID: 36728830
[TBL] [Abstract][Full Text] [Related]
16. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
17. Structural and quantitative evidence of α2-6-sialylated N-glycans as markers of the differentiation potential of human mesenchymal stem cells.
Hasehira K; Hirabayashi J; Tateno H
Glycoconj J; 2017 Dec; 34(6):797-806. PubMed ID: 27314244
[TBL] [Abstract][Full Text] [Related]
18. Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.
Tang H; Singh S; Partyka K; Kletter D; Hsueh P; Yadav J; Ensink E; Bern M; Hostetter G; Hartman D; Huang Y; Brand RE; Haab BB
Mol Cell Proteomics; 2015 May; 14(5):1323-33. PubMed ID: 25733690
[TBL] [Abstract][Full Text] [Related]
19. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
[TBL] [Abstract][Full Text] [Related]
20. Integrated Systems Analysis of the Murine and Human Pancreatic Cancer Glycomes Reveals a Tumor-Promoting Role for ST6GAL1.
Kurz E; Chen S; Vucic E; Baptiste G; Loomis C; Agrawal P; Hajdu C; Bar-Sagi D; Mahal LK
Mol Cell Proteomics; 2021; 20():100160. PubMed ID: 34634466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]